Skip to content
lifestyle.brownplanet.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Nordic Pharma
SEVER LIFE SCIENCES B.V. THROUGH ITS SUBSIDIARY NORDIC PHARMA, INC. (U.S.), TO SHARE PATIENT DATA AND PATIENT EXPERIENCE STUDY FOR LACRIFILL® CANALICULAR GEL, A NOVEL THERAPY FOR OCULAR SURFACE CONTROL, DURING AMERICAN ACADEMY OF OPHTHALMOLOGY (AAO) 2026
October 7, 2026